For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...
A clinical trial to test the effectiveness of a new, plant-based oral drug to treat type 2 diabetes has produced some ...
Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...
Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...
Diabetes affects more than 1 in 10 adults worldwide and has been accompanied by an increase in vision-threatening diabetic ...
The UK healthcare landscape is set for a major shake-up following Prime Minister Keir Starmer’s announcement that NHS England ...
Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...
Use of GLP-1 receptor agonists for obesity was associated with a reduced risk of primary open-angle glaucoma (POAG) and ...